Ignite Creation Date:
2025-12-25 @ 12:20 AM
Ignite Modification Date:
2026-02-12 @ 4:45 PM
Study NCT ID:
NCT02684058
Status:
COMPLETED
Last Update Posted:
2023-12-13
First Post:
2016-02-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-28
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-04
First Submit QC Date:
None
Study First Post Date:
2016-02-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-04-13
Results First Submit QC Date:
None
Results First Post Date:
2023-05-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-08-11
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-11-20
Last Update Post Date:
2023-12-13
Last Update Post Date Type:
ACTUAL